NEURAGENEX Trademark

Trademark Overview

On Tuesday, October 1, 2019, a trademark application was filed for NEURAGENEX with the United States Patent and Trademark Office. The USPTO has given the NEURAGENEX trademark a serial number of 88638439. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, August 2, 2023. The NEURAGENEX trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Health care; Ancillary medical services in the field of neuropathy and pain treatment
neuragenex

General Information

Serial Number88638439
Word MarkNEURAGENEX
Filing DateTuesday, October 1, 2019
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, August 2, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesHealth care; Ancillary medical services in the field of neuropathy and pain treatment

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, October 4, 2019
Primary Code044
First Use Anywhere DateSunday, September 1, 2019
First Use In Commerce DateSunday, September 1, 2019

Trademark Owner History

Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressGILBERT, AZ 852977327

Trademark Events

Event DateEvent Description
Wednesday, August 2, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Wednesday, August 2, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Wednesday, August 2, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, April 18, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, April 18, 2023FINAL REFUSAL E-MAILED
Tuesday, April 18, 2023FINAL REFUSAL WRITTEN
Wednesday, February 22, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 22, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 22, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, January 19, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, January 19, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, January 19, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, January 12, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, January 12, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, January 12, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, August 22, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 22, 2022NON-FINAL ACTION E-MAILED
Monday, August 22, 2022NON-FINAL ACTION WRITTEN
Wednesday, July 27, 2022SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
Monday, January 24, 2022REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, July 8, 2021REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, August 10, 2020NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, August 10, 2020LETTER OF SUSPENSION E-MAILED
Monday, August 10, 2020SUSPENSION LETTER WRITTEN
Wednesday, July 8, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 7, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 7, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, January 9, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, January 9, 2020NON-FINAL ACTION E-MAILED
Thursday, January 9, 2020NON-FINAL ACTION WRITTEN
Saturday, January 4, 2020ASSIGNED TO EXAMINER
Friday, October 4, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, October 4, 2019NEW APPLICATION ENTERED

Related Keywords

neuragenex neuropathy pain treatment field services care ancillary medical health